Search

Amplyx Pharmaceuticals, a drug development firm developing small molecule drugs, has raised a Series A funding round, worth roughly $700K. The funding came from the Tech Coast Angels and life Science Angels. According to the Tech Coast Angels, an angel investment group in Southern California, the round was led by Life Science Angels, which invested $492,000 in Amplyx, with an additional $289,000 coming from members of the TCA. Amplyx is developing compounds which can help in addressing absorption, distribution, metabolism and excretion problems with existing drugs.
posted on Monday, September 22, 2008 (Link to more information)

Related companies:
Amplyx Pharmaceuticals

Related stories:
> Amplyx Pharmaceuticals Absorbs $1.5M
> Bridge Pharmaceuticals Raises $35M
> TransOral Pharmaceuticals Raises $40M
> MicuRx Raises $10M
> KaloBios Pharmaceuticals Raises $12M

---

silicontap.com Home